A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Partnering with Texas pathology group enables a genetics-focused strategy to address the hidden epidemic of celiac diseaseIRVINE, Calif. and SAN ANTONIO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Targeted ...

The global diagnostic tools market, covering medical diagnostics and imaging, is experiencing robust growth. Key drivers ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

The eels, including breeding stock thought to be 40 to 50 years old, were found dead in the Waiatāi Stream near Wairoa last ...

Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years ...

It has been 34 years since I first set foot on the African continent. Over this time, I have met countless people—from locals to foreigners from the United States, the United Kingdom, Germany, Russia, ...

The BBC's long-running crime drama gives us simple, concise murder mysteries. That's why it's stood the test of time ...

New microbiome data show that intestinal bacteria can generate clinically relevant alcohol levels, validating a rare syndrome ...

Dr. Thaïs Aliabadi, an OB-GYN, wanted a preventive double-mastectomy. She fought to get it, then learned she already had ...

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...